Cold chain development

Located close to its existing premises in Theale, the 26,000 sq ft building will expand Tower’s container conditioning and storage capacities, as well as enhancing its design, laboratory and testing capabilities in the development of temperature-controlled pharmaceutical supply chain solutions.

The HQ features an innovation centre and office space which is available for customer use, providing opportunities for meetings and product assessments.

In addition, the expanded laboratory facilities include two new environmental test chambers with a larger capacity for qualification and development of new product ranges.

“This is another important milestone in the continued growth of Tower,” says Tower CEO Niall Balfour. “We are experiencing increasing demand for our range of services to support the fast and efficient distribution of temperature-critical pharmaceuticals and life science products, ensuring they maintain their efficacy to deliver the best result for the end-patient.

“The additional space and facilities in our new premises further strengthen our collaborative approach, which is at the heart of every project, and will enable us to react even more quickly to customer requests.”

The HQ will also support Tower’s hubs throughout Europe, the USA, Asia-Pacific, India and South Africa. Tower’s product offering also means it can supply containers at all pharmaceutical temperature configurations and standards to meet the different requirements of Euro, US, single and double pallets, as well as smaller sub-pallet consignments.

The company was one of the first to adopt phase-change materials to protect temperature-sensitive materials, as well as developing a patented built-in data logger for its products. More recently, Tower introduced a range of unique biotechnology deep frozen pack-out solutions. In its last 15,000 shipments, the company has recorded fewer than 0.1% temperature excursions.

For more information, visit www.towercoldchain.com